Global Denosumab Market Growth (Status and Outlook) 2022-2028
- LP 4948965
- 63 Pages
- April 2022
- Medical Devices
The United States Denosumab market is expected at value of US$ million in 2021 and grow at approximately % CAGR during forecast period 2022-2028. China constitutes a % market for the global Denosumab market, reaching US$ million by the year 2028. As for the Europe Denosumab landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 6-year period.
Global main Denosumab players cover Amgen, Qilu Pharmaceutical, Shandong Boan Biotech, and Shanghai Mabwell, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Denosumab market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
60 mg
120 mg
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Hospital
Clinic
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Amgen
Qilu Pharmaceutical
Shandong Boan Biotech
Shanghai Mabwell
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Denosumab Market Size 2017-2028
2.1.2 Denosumab Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Denosumab Segment by Type
2.2.1 60 mg
2.2.2 120 mg
2.3 Denosumab Market Size by Type
2.3.1 Denosumab Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Denosumab Market Size Market Share by Type (2017-2022)
2.4 Denosumab Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Others
2.5 Denosumab Market Size by Application
2.5.1 Denosumab Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Denosumab Market Size Market Share by Application (2017-2022)
3 Denosumab Market Size by Player
3.1 Denosumab Market Size Market Share by Players
3.1.1 Global Denosumab Revenue by Players (2020-2022)
3.1.2 Global Denosumab Revenue Market Share by Players (2020-2022)
3.2 Global Denosumab Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Denosumab by Regions
4.1 Denosumab Market Size by Regions (2017-2022)
4.2 Americas Denosumab Market Size Growth (2017-2022)
4.3 APAC Denosumab Market Size Growth (2017-2022)
4.4 Europe Denosumab Market Size Growth (2017-2022)
4.5 Middle East & Africa Denosumab Market Size Growth (2017-2022)
5 Americas
5.1 Americas Denosumab Market Size by Country (2017-2022)
5.2 Americas Denosumab Market Size by Type (2017-2022)
5.3 Americas Denosumab Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Denosumab Market Size by Region (2017-2022)
6.2 APAC Denosumab Market Size by Type (2017-2022)
6.3 APAC Denosumab Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Denosumab by Country (2017-2022)
7.2 Europe Denosumab Market Size by Type (2017-2022)
7.3 Europe Denosumab Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Denosumab by Region (2017-2022)
8.2 Middle East & Africa Denosumab Market Size by Type (2017-2022)
8.3 Middle East & Africa Denosumab Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Denosumab Market Forecast
10.1 Global Denosumab Forecast by Regions (2023-2028)
10.1.1 Global Denosumab Forecast by Regions (2023-2028)
10.1.2 Americas Denosumab Forecast
10.1.3 APAC Denosumab Forecast
10.1.4 Europe Denosumab Forecast
10.1.5 Middle East & Africa Denosumab Forecast
10.2 Americas Denosumab Forecast by Country (2023-2028)
10.2.1 United States Denosumab Market Forecast
10.2.2 Canada Denosumab Market Forecast
10.2.3 Mexico Denosumab Market Forecast
10.2.4 Brazil Denosumab Market Forecast
10.3 APAC Denosumab Forecast by Region (2023-2028)
10.3.1 China Denosumab Market Forecast
10.3.2 Japan Denosumab Market Forecast
10.3.3 Korea Denosumab Market Forecast
10.3.4 Southeast Asia Denosumab Market Forecast
10.3.5 India Denosumab Market Forecast
10.3.6 Australia Denosumab Market Forecast
10.4 Europe Denosumab Forecast by Country (2023-2028)
10.4.1 Germany Denosumab Market Forecast
10.4.2 France Denosumab Market Forecast
10.4.3 UK Denosumab Market Forecast
10.4.4 Italy Denosumab Market Forecast
10.4.5 Russia Denosumab Market Forecast
10.5 Middle East & Africa Denosumab Forecast by Region (2023-2028)
10.5.1 Egypt Denosumab Market Forecast
10.5.2 South Africa Denosumab Market Forecast
10.5.3 Israel Denosumab Market Forecast
10.5.4 Turkey Denosumab Market Forecast
10.5.5 GCC Countries Denosumab Market Forecast
10.6 Global Denosumab Forecast by Type (2023-2028)
10.7 Global Denosumab Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 Amgen
11.1.1 Amgen Company Information
11.1.2 Amgen Denosumab Product Offered
11.1.3 Amgen Denosumab Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Amgen Main Business Overview
11.1.5 Amgen Latest Developments
11.2 Qilu Pharmaceutical
11.2.1 Qilu Pharmaceutical Company Information
11.2.2 Qilu Pharmaceutical Denosumab Product Offered
11.2.3 Qilu Pharmaceutical Denosumab Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Qilu Pharmaceutical Main Business Overview
11.2.5 Qilu Pharmaceutical Latest Developments
11.3 Shandong Boan Biotech
11.3.1 Shandong Boan Biotech Company Information
11.3.2 Shandong Boan Biotech Denosumab Product Offered
11.3.3 Shandong Boan Biotech Denosumab Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Shandong Boan Biotech Main Business Overview
11.3.5 Shandong Boan Biotech Latest Developments
11.4 Shanghai Mabwell
11.4.1 Shanghai Mabwell Company Information
11.4.2 Shanghai Mabwell Denosumab Product Offered
11.4.3 Shanghai Mabwell Denosumab Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Shanghai Mabwell Main Business Overview
11.4.5 Shanghai Mabwell Latest Developments
12 Research Findings and Conclusion
Table 1. Denosumab Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of 60 mg
Table 3. Major Players of 120 mg
Table 4. Denosumab Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 5. Global Denosumab Market Size by Type (2017-2022) & ($ Millions)
Table 6. Global Denosumab Market Size Market Share by Type (2017-2022)
Table 7. Denosumab Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 8. Global Denosumab Market Size by Application (2017-2022) & ($ Millions)
Table 9. Global Denosumab Market Size Market Share by Application (2017-2022)
Table 10. Global Denosumab Revenue by Players (2020-2022) & ($ Millions)
Table 11. Global Denosumab Revenue Market Share by Player (2020-2022)
Table 12. Denosumab Key Players Head office and Products Offered
Table 13. Denosumab Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Denosumab Market Size by Regions 2017-2022 & ($ Millions)
Table 17. Global Denosumab Market Size Market Share by Regions (2017-2022)
Table 18. Americas Denosumab Market Size by Country (2017-2022) & ($ Millions)
Table 19. Americas Denosumab Market Size Market Share by Country (2017-2022)
Table 20. Americas Denosumab Market Size by Type (2017-2022) & ($ Millions)
Table 21. Americas Denosumab Market Size Market Share by Type (2017-2022)
Table 22. Americas Denosumab Market Size by Application (2017-2022) & ($ Millions)
Table 23. Americas Denosumab Market Size Market Share by Application (2017-2022)
Table 24. APAC Denosumab Market Size by Region (2017-2022) & ($ Millions)
Table 25. APAC Denosumab Market Size Market Share by Region (2017-2022)
Table 26. APAC Denosumab Market Size by Type (2017-2022) & ($ Millions)
Table 27. APAC Denosumab Market Size Market Share by Type (2017-2022)
Table 28. APAC Denosumab Market Size by Application (2017-2022) & ($ Millions)
Table 29. APAC Denosumab Market Size Market Share by Application (2017-2022)
Table 30. Europe Denosumab Market Size by Country (2017-2022) & ($ Millions)
Table 31. Europe Denosumab Market Size Market Share by Country (2017-2022)
Table 32. Europe Denosumab Market Size by Type (2017-2022) & ($ Millions)
Table 33. Europe Denosumab Market Size Market Share by Type (2017-2022)
Table 34. Europe Denosumab Market Size by Application (2017-2022) & ($ Millions)
Table 35. Europe Denosumab Market Size Market Share by Application (2017-2022)
Table 36. Middle East & Africa Denosumab Market Size by Region (2017-2022) & ($ Millions)
Table 37. Middle East & Africa Denosumab Market Size Market Share by Region (2017-2022)
Table 38. Middle East & Africa Denosumab Market Size by Type (2017-2022) & ($ Millions)
Table 39. Middle East & Africa Denosumab Market Size Market Share by Type (2017-2022)
Table 40. Middle East & Africa Denosumab Market Size by Application (2017-2022) & ($ Millions)
Table 41. Middle East & Africa Denosumab Market Size Market Share by Application (2017-2022)
Table 42. Key Market Drivers & Growth Opportunities of Denosumab
Table 43. Key Market Challenges & Risks of Denosumab
Table 44. Key Industry Trends of Denosumab
Table 45. Global Denosumab Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 46. Global Denosumab Market Size Market Share Forecast by Regions (2023-2028)
Table 47. Global Denosumab Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 48. Global Denosumab Market Size Market Share Forecast by Type (2023-2028)
Table 49. Global Denosumab Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 50. Global Denosumab Market Size Market Share Forecast by Application (2023-2028)
Table 51. Amgen Details, Company Type, Denosumab Area Served and Its Competitors
Table 52. Amgen Denosumab Product Offered
Table 53. Amgen Denosumab Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 54. Amgen Main Business
Table 55. Amgen Latest Developments
Table 56. Qilu Pharmaceutical Details, Company Type, Denosumab Area Served and Its Competitors
Table 57. Qilu Pharmaceutical Denosumab Product Offered
Table 58. Qilu Pharmaceutical Main Business
Table 59. Qilu Pharmaceutical Denosumab Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 60. Qilu Pharmaceutical Latest Developments
Table 61. Shandong Boan Biotech Details, Company Type, Denosumab Area Served and Its Competitors
Table 62. Shandong Boan Biotech Denosumab Product Offered
Table 63. Shandong Boan Biotech Main Business
Table 64. Shandong Boan Biotech Denosumab Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 65. Shandong Boan Biotech Latest Developments
Table 66. Shanghai Mabwell Details, Company Type, Denosumab Area Served and Its Competitors
Table 67. Shanghai Mabwell Denosumab Product Offered
Table 68. Shanghai Mabwell Main Business
Table 69. Shanghai Mabwell Denosumab Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 70. Shanghai Mabwell Latest Developments
List of Figures
Figure 1. Denosumab Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Denosumab Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Denosumab Market Size Market Share by Type in 2021
Figure 7. Denosumab in Hospital
Figure 8. Global Denosumab Market: Hospital (2017-2022) & ($ Millions)
Figure 9. Denosumab in Clinic
Figure 10. Global Denosumab Market: Clinic (2017-2022) & ($ Millions)
Figure 11. Denosumab in Others
Figure 12. Global Denosumab Market: Others (2017-2022) & ($ Millions)
Figure 13. Global Denosumab Market Size Market Share by Application in 2021
Figure 14. Global Denosumab Revenue Market Share by Player in 2021
Figure 15. Global Denosumab Market Size Market Share by Regions (2017-2022)
Figure 16. Americas Denosumab Market Size 2017-2022 ($ Millions)
Figure 17. APAC Denosumab Market Size 2017-2022 ($ Millions)
Figure 18. Europe Denosumab Market Size 2017-2022 ($ Millions)
Figure 19. Middle East & Africa Denosumab Market Size 2017-2022 ($ Millions)
Figure 20. Americas Denosumab Value Market Share by Country in 2021
Figure 21. Americas Denosumab Consumption Market Share by Type in 2021
Figure 22. Americas Denosumab Market Size Market Share by Application in 2021
Figure 23. United States Denosumab Market Size Growth 2017-2022 ($ Millions)
Figure 24. Canada Denosumab Market Size Growth 2017-2022 ($ Millions)
Figure 25. Mexico Denosumab Market Size Growth 2017-2022 ($ Millions)
Figure 26. Brazil Denosumab Market Size Growth 2017-2022 ($ Millions)
Figure 27. APAC Denosumab Market Size Market Share by Region in 2021
Figure 28. APAC Denosumab Market Size Market Share by Application in 2021
Figure 29. China Denosumab Market Size Growth 2017-2022 ($ Millions)
Figure 30. Japan Denosumab Market Size Growth 2017-2022 ($ Millions)
Figure 31. Korea Denosumab Market Size Growth 2017-2022 ($ Millions)
Figure 32. Southeast Asia Denosumab Market Size Growth 2017-2022 ($ Millions)
Figure 33. India Denosumab Market Size Growth 2017-2022 ($ Millions)
Figure 34. Australia Denosumab Market Size Growth 2017-2022 ($ Millions)
Figure 35. Europe Denosumab Market Size Market Share by Country in 2021
Figure 36. Europe Denosumab Market Size Market Share by Type in 2021
Figure 37. Europe Denosumab Market Size Market Share by Application in 2021
Figure 38. Germany Denosumab Market Size Growth 2017-2022 ($ Millions)
Figure 39. France Denosumab Market Size Growth 2017-2022 ($ Millions)
Figure 40. UK Denosumab Market Size Growth 2017-2022 ($ Millions)
Figure 41. Italy Denosumab Market Size Growth 2017-2022 ($ Millions)
Figure 42. Russia Denosumab Market Size Growth 2017-2022 ($ Millions)
Figure 43. Middle East & Africa Denosumab Market Size Market Share by Region in 2021
Figure 44. Middle East & Africa Denosumab Market Size Market Share by Type in 2021
Figure 45. Middle East & Africa Denosumab Market Size Market Share by Application in 2021
Figure 46. Egypt Denosumab Market Size Growth 2017-2022 ($ Millions)
Figure 47. South Africa Denosumab Market Size Growth 2017-2022 ($ Millions)
Figure 48. Israel Denosumab Market Size Growth 2017-2022 ($ Millions)
Figure 49. Turkey Denosumab Market Size Growth 2017-2022 ($ Millions)
Figure 50. GCC Country Denosumab Market Size Growth 2017-2022 ($ Millions)
Figure 51. Americas Denosumab Market Size 2023-2028 ($ Millions)
Figure 52. APAC Denosumab Market Size 2023-2028 ($ Millions)
Figure 53. Europe Denosumab Market Size 2023-2028 ($ Millions)
Figure 54. Middle East & Africa Denosumab Market Size 2023-2028 ($ Millions)
Figure 55. United States Denosumab Market Size 2023-2028 ($ Millions)
Figure 56. Canada Denosumab Market Size 2023-2028 ($ Millions)
Figure 57. Mexico Denosumab Market Size 2023-2028 ($ Millions)
Figure 58. Brazil Denosumab Market Size 2023-2028 ($ Millions)
Figure 59. China Denosumab Market Size 2023-2028 ($ Millions)
Figure 60. Japan Denosumab Market Size 2023-2028 ($ Millions)
Figure 61. Korea Denosumab Market Size 2023-2028 ($ Millions)
Figure 62. Southeast Asia Denosumab Market Size 2023-2028 ($ Millions)
Figure 63. India Denosumab Market Size 2023-2028 ($ Millions)
Figure 64. Australia Denosumab Market Size 2023-2028 ($ Millions)
Figure 65. Germany Denosumab Market Size 2023-2028 ($ Millions)
Figure 66. France Denosumab Market Size 2023-2028 ($ Millions)
Figure 67. UK Denosumab Market Size 2023-2028 ($ Millions)
Figure 68. Italy Denosumab Market Size 2023-2028 ($ Millions)
Figure 69. Russia Denosumab Market Size 2023-2028 ($ Millions)
Figure 70. Spain Denosumab Market Size 2023-2028 ($ Millions)
Figure 71. Egypt Denosumab Market Size 2023-2028 ($ Millions)
Figure 72. South Africa Denosumab Market Size 2023-2028 ($ Millions)
Figure 73. Israel Denosumab Market Size 2023-2028 ($ Millions)
Figure 74. Turkey Denosumab Market Size 2023-2028 ($ Millions)
Figure 75. GCC Countries Denosumab Market Size 2023-2028 ($ Millions)
Similar Reports
This report provides an overview of the French molecular diagnostic testing market, including test volume, and sales forecasts by Application, 2019-2023, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
This report provides an overview of the German molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...
- Publish Date: April 1, 2019
- $450
This report provides an overview of the Italian molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...
- Publish Date: April 1, 2019
- $450
